Clinical Trials

Showing 481 - 492 of 492 trials
Title Investigatorsort icon Disease(s)
A Phase II Study of Neoadjuvant Dose-Dense Gemcitabine and Cisplatin in Patients with Muscle-Invasive Bladder Cancer
[Protocol 12-071]
Bajorin, Dean
  • Bladder Cancer
A Phase I Study of AM0010 in Patients with Advanced Solid Tumors
[Protocol 13-224]
Autio, Karen
  • Colorectal Cancer
  • Kidney Cancer
  • Lung Cancer
  • Melanoma
  • Ovarian Cancer
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
  • Upper Gastrointestinal
    • Pancreatic Cancer
A Phase II Study of Degarelix plus Ipilimumab with Radical Prostatectomy in Men Newly Diagnosed with Metastatic Prostate Cancer
[Protocol 13-134]
Autio, Karen
  • Prostate Cancer
A Study Comparing Standard Fluid Management with a Device for Goal-Directed Fluid Management in Patients Undergoing Bladder Removal Surgery
Newly Diagnosed & Relapsed/Refractory
[Protocol 14-069]
Arslan Carlon, Vittoria
  • Bladder Cancer
A Phase II Study of Ipilimumab Plus Isolated Limb Infusion with Melphalan and Dactinomycin to Treat Advanced Unresectable Melanoma of the Extremity
[Protocol 10-101]
Ariyan, Charlotte
  • Melanoma
Risk for Cognitive Decline in Older Women with Breast Cancer
[Protocol 10-079]
Ahles, Tim
  • Breast Cancer
Cognition in Older Breast Cancer Survivors: Influence of Treatment, Genetics, and Smoking History
[Protocol 14-071]
Ahles, Tim
  • Breast Cancer
  • Survivorship
A Phase II/III Study of Paclitaxel/Carboplatin with and without Metformin for Treating Stage III or IV or Recurrent Endometrial Cancer
[Protocol 14-081]
Aghajanian, Carol
  • Uterine (Endometrial) Cancer
A Phase IB Study of Dalantercept plus Sorafenib in Patients with Advanced Liver Cancer
[Protocol 14-092]
Abou-Alfa, Ghassan
  • Hepatobiliary
    • Liver Cancer
A Phase II Study of Sorafenib plus Doxorubicin in Patients with Liver Cancer that Continued Growing with Sorafenib Therapy
[Protocol 12-259]
Abou-Alfa, Ghassan
  • Hepatobiliary
    • Liver Cancer
A Phase II Study of Everolimus, Leuprolide/Letrozole, and Everolimus/Leuprolide/Letrozole in Patients with Inoperable Fibrolamellar Hepatocellular Carcinoma
Newly Diagnosed & Relapsed/Refractory
[Protocol 11-211]
Abou-Alfa, Ghassan
  • Hepatobiliary
    • Liver Cancer
A Phase III Study of Cabozantinib versus Placebo in Patients with Liver Cancer Who Received Previous Therapy with Sorafenib
[Protocol 13-151]
Abou-Alfa, Ghassan
  • Hepatobiliary
    • Liver Cancer